Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene
- 1 December 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 317 (2-3) , 239-245
- https://doi.org/10.1016/s0014-2999(96)00746-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prolonged postictal depression in amygdala-kindled rats by the adenosine analog, l-phenylisopropyladenosinePublished by Elsevier ,2004
- Prolonged agonist exposure induces imbalance of A1 and A2 receptor‐mediated functions in rat brain slicesDrug Development Research, 1993
- Neuroprotective role of adenosine in cerebral ischaemiaTrends in Pharmacological Sciences, 1992
- Selective A1-Antagonists for Treatment of Cognitive DeficitsNucleosides and Nucleotides, 1991
- Physiological and pharmacological properties of adenosine: Therapeutic implicationsLife Sciences, 1991
- NECA-induced hypomotility in mice: Evidence for a predominantly central site of actionPharmacology Biochemistry and Behavior, 1989
- Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion.Journal of Clinical Investigation, 1988
- Neuroprotective effects of adenosineTrends in Pharmacological Sciences, 1988
- Is Adenosine an Endogenous Anticonvulsant?Epilepsia, 1985
- Anticonvulsant actions of DS 103–282: Pharmacological studies in rodents and the baboon, Papio papioNeuropharmacology, 1984